RPID vs. EYPT, ALNT, CTKB, LAB, AEHR, SENS, QSI, MASS, QTRX, and FEIM
Should you be buying Rapid Micro Biosystems stock or one of its competitors? The main competitors of Rapid Micro Biosystems include EyePoint Pharmaceuticals (EYPT), Allient (ALNT), Cytek Biosciences (CTKB), Standard BioTools (LAB), Aehr Test Systems (AEHR), Senseonics (SENS), Quantum-Si (QSI), 908 Devices (MASS), Quanterix (QTRX), and Frequency Electronics (FEIM). These companies are all part of the "measuring and control equipment" industry.
Rapid Micro Biosystems vs. Its Competitors
Rapid Micro Biosystems (NASDAQ:RPID) and EyePoint Pharmaceuticals (NASDAQ:EYPT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, community ranking, valuation, media sentiment, analyst recommendations, profitability, dividends, institutional ownership and risk.
Rapid Micro Biosystems has higher earnings, but lower revenue than EyePoint Pharmaceuticals. EyePoint Pharmaceuticals is trading at a lower price-to-earnings ratio than Rapid Micro Biosystems, indicating that it is currently the more affordable of the two stocks.
EyePoint Pharmaceuticals received 465 more outperform votes than Rapid Micro Biosystems when rated by MarketBeat users. Likewise, 70.40% of users gave EyePoint Pharmaceuticals an outperform vote while only 35.29% of users gave Rapid Micro Biosystems an outperform vote.
Rapid Micro Biosystems has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, EyePoint Pharmaceuticals has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500.
Rapid Micro Biosystems currently has a consensus target price of $8.00, suggesting a potential upside of 128.57%. EyePoint Pharmaceuticals has a consensus target price of $25.38, suggesting a potential upside of 185.11%. Given EyePoint Pharmaceuticals' higher probable upside, analysts clearly believe EyePoint Pharmaceuticals is more favorable than Rapid Micro Biosystems.
Rapid Micro Biosystems has a net margin of -184.93% compared to EyePoint Pharmaceuticals' net margin of -226.57%. EyePoint Pharmaceuticals' return on equity of -43.01% beat Rapid Micro Biosystems' return on equity.
In the previous week, EyePoint Pharmaceuticals had 7 more articles in the media than Rapid Micro Biosystems. MarketBeat recorded 11 mentions for EyePoint Pharmaceuticals and 4 mentions for Rapid Micro Biosystems. Rapid Micro Biosystems' average media sentiment score of 1.34 beat EyePoint Pharmaceuticals' score of 0.77 indicating that Rapid Micro Biosystems is being referred to more favorably in the media.
52.6% of Rapid Micro Biosystems shares are held by institutional investors. Comparatively, 99.4% of EyePoint Pharmaceuticals shares are held by institutional investors. 30.0% of Rapid Micro Biosystems shares are held by insiders. Comparatively, 4.5% of EyePoint Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
EyePoint Pharmaceuticals beats Rapid Micro Biosystems on 11 of the 19 factors compared between the two stocks.
Get Rapid Micro Biosystems News Delivered to You Automatically
Sign up to receive the latest news and ratings for RPID and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding RPID and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Rapid Micro Biosystems Competitors List
Related Companies and Tools
This page (NASDAQ:RPID) was last updated on 6/17/2025 by MarketBeat.com Staff
Buy RPID Stock Free RPID Stock Alerts